Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A randomized, double-blind, placebo-controlled, crossover study of respiratory safety of lemborexant in moderate to severe obstructive sleep apnea
Jocelyn Y. Cheng, Daniel Lorch, Alan Lowe, et al.
Journal of Clinical Sleep Medicine (2023) Vol. 20, Iss. 1, pp. 57-65
Closed Access | Times Cited: 9

Showing 9 citing articles:

Comorbidities in COPD: Current and Future Treatment Challenges
Domenica Francesca Mariniello, Vito D’Agnano, Donatella Cennamo, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 3, pp. 743-743
Open Access | Times Cited: 12
Treatment of OSA and its Impact on Cardiovascular Disease, Part 2
Shahrokh Javaheri, Sogol Javaheri, David Gozal, et al.
Journal of the American College of Cardiology (2024) Vol. 84, Iss. 13, pp. 1224-1240
Closed Access | Times Cited: 6
Response to “Letter to the editor regarding ‘Effect of lemborexant on sleep architecture in participants with insomnia disorder and mild obstructive sleep apnea’ by Kushida et al.”
Clete A. Kushida, Gary Zammit, Jocelyn Y. Cheng, et al.
Sleep Medicine (2025) Vol. 128, pp. 195-195
Closed Access
Proposal for Managing Cancer‐Related Insomnia: A Systematic Literature Review of Associated Factors and a Narrative Review of Treatment
Yoshinori Saeki, Yukiyoshi Sumi, Yukinori Ozaki, et al.
Cancer Medicine (2024) Vol. 13, Iss. 22
Open Access | Times Cited: 3
Effect of lemborexant on sleep architecture in participants with insomnia disorder and mild obstructive sleep apnea
Clete A. Kushida, Gary Zammit, Jocelyn Y. Cheng, et al.
Sleep Medicine (2024)
Open Access | Times Cited: 2
Pharmacological Treatments of Sleep–Wake Disorders: Update 2023
Marcel S. Kallweit, Nayeli P. Kallweit, Ulf Kallweit
Clinical and Translational Neuroscience (2023) Vol. 7, Iss. 4, pp. 42-42
Open Access | Times Cited: 4
Pharmacological Treatments of Sleep-Wake Disorders: Update 2023
Marcel S. Kallweit, Nayeli P. Kallweit, Ulf Kallweit
(2023)
Open Access | Times Cited: 2
The efficacy and safety of dual orexin receptor antagonists in obstructive sleep apnea: A systematic review and meta‐analysis of randomised controlled trials
Wei‐Chih Yeh, Ying‐Sheng Li, Yang‐Pei Chang, et al.
Journal of Sleep Research (2024)
Open Access
Phase 1b/2a Safety Study of Lemborexant as an Adjunctive Treatment for Insomnia to Buprenorphine-Naloxone for Opioid Use Disorder: A Randomized Controlled Trial
Caitlin Martin, James M. Bjork, Lori Keyser‐Marcus, et al.
Drug and Alcohol Dependence Reports (2024) Vol. 14, pp. 100304-100304
Open Access
Page 1

Scroll to top